Article
Immune response to SARS-CoV-2 variants of concern in vaccinated individuals.
Nature communications - 25 May 2021
Becker Matthias, Dulovic Alex, Junker Daniel, Ruetalo Natalia, Kaiser Philipp D, Pinilla Yudi T, Heinzel Constanze, Haering Julia, Traenkle Bjoern, Wagner Teresa R, Layer Mirjam, Mehrlaender Martin, Mirakaj Valbona, Held Jana, Planatscher Hannes, Schenke-Layland Katja, Krause Gérard, Strengert Monika, Bakchoul Tamam, Althaus Karina, Fendel Rolf, Kreidenweiss Andrea, Koeppen Michael, Rothbauer Ulrich, Schindler Michael, Schneiderhan-Marra Nicole
Abstract excerpt
SARS-CoV-2 is evolving with mutations in the receptor binding domain (RBD) being of particular concern. It is important to know how much cross-protection is offered between strains following vaccination or infection. Here, we obtain serum and saliva samples from groups of vaccinated (Pfizer BNT-162b2), infected and uninfected individuals and characterize the antibody response to RBD mutant strains. Vaccinated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
